Epstein-Barr virus-associated lymphoproliferative disorders

被引:199
|
作者
Rezk, Sherif A. [1 ]
Weiss, Lawrence M. [1 ]
机构
[1] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA 91010 USA
关键词
epstein-Barr virus; B-cell lymphoproliferative; disorders; T-cell lymphoproliferative; HIV-associated lymphoproliferative disorders;
D O I
10.1016/j.humpath.2007.05.020
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Epstein-Barr virus (EBV) is a member of the human herpesvirus family that was initially isolated from a cultured Burkitt lymphoma cell line by Epstein et al in 1964. Subsequent studies have proven that it is the causative agent in most cases of infectious mononucleosis. Primary infection is usually asymptomatic in childhood; but in adulthood, it is associated with a self-limiting infectious mononucleosis syndrome in approximately one third of the cases. EBV has been linked to many human neoplasms including hematopoietic, epithelial, and mesenchymal tumors. In this review, we will only discuss the EBV-associated lymphoproliferative disorders, dividing them into B-cell, T/NK-cell, and HIV-related lymphoproliferative disorders. (c) 2007 Published by Elsevier Inc.
引用
收藏
页码:1293 / 1304
页数:12
相关论文
共 50 条
  • [1] EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS
    PURTILO, DT
    STROBACH, RS
    OKANO, M
    DAVIS, JR
    [J]. LABORATORY INVESTIGATION, 1992, 67 (01) : 5 - 23
  • [2] Epstein-Barr virus-associated lymphoproliferative disorders
    Grywalska, Ewelina
    Markowicz, Justyna
    Grabarczyk, Piotr
    Pasiarski, Marcin
    Rolinski, Jacek
    [J]. POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2013, 67 : 481 - 490
  • [3] EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS
    SCHUSTER, V
    KRETH, HW
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 1991, 139 (07) : 396 - 400
  • [4] Treatment of Epstein-Barr virus-associated posttransplant lymphoproliferative disorders
    Gross, TG
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2001, 23 (01) : 7 - 9
  • [5] EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS IN IMMUNOCOMPROMISED INDIVIDUALS
    THOMAS, JA
    ALLDAY, MJ
    CRAWFORD, DH
    [J]. ADVANCES IN CANCER RESEARCH, 1991, 57 : 329 - 380
  • [6] Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments
    Geng, Lingyun
    Wang, Xin
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (09): : 14656 - 14671
  • [7] Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders
    Iwatsuki, K
    Ohtsuka, M
    Harada, H
    Han, GW
    Kaneko, F
    [J]. ARCHIVES OF DERMATOLOGY, 1997, 133 (09) : 1081 - 1086
  • [8] Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders
    Yang, Xi
    Nishida, Naonori
    Zhao, Xiaodong
    Kanegane, Hirokazu
    [J]. IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2015, 14 (05) : 462 - 471
  • [9] FATAL EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDER IN CHILDHOOD
    YATABE, Y
    MORI, N
    OKA, K
    IIJIMA, T
    SAGA, S
    TAKADA, K
    ASAI, J
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1995, 119 (05) : 409 - 417
  • [10] Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?
    Robertson, MJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (06): : 801 - 802